ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
Links shared publicly online about this topic.
- 1,308total visits
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmo
View full resource at medicalnewstoday.com
Tags: Diabetes, Type 2 Diabetes
Most Recently Shared on March 17, 2010 at 10:11 pm By:
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Acad... http://mnt.to/3z37
Also Shared By:
ACCORD Lipid Study Brings new Hope to People With Type... -- ATLANTA, Georgia, March 14, 2010 /PRNewswire/ --
prnewswire.com — “ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation.” View full resource at prnewswire.com
Most Recently Shared on March 14, 2010 at 4:08 pm By:
ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia http://bit.ly/bYFGDs /via @AllisonHarkett
Advertisement
MNT Cholesterol News
@mnt_cholesterol
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Acad... http://mnt.to/3z37
1 year ago...